Marna Borgstrom - CryoLife Independent Director
Director
Ms. Marna P. Borgstrom serves as Independent Director of the Company. She was recommended by a third party search firm. Since 2005, Ms. Borgstrom was President, Chief Executive Officer, and a board member of the Yale New Haven Health System, an integrated health care delivery system that operates in Connecticut, western Rhode Island, and Westchester County, New York. Additionally, Ms. Borgstrom currently serves on several nationally recognized boards including Vizient, Inc., a privately held, memberdriven health care performance improvement company, the Coalition to Protect America Healthcare, and the Healthcare Institute since 2018.
| Age | 66 |
| Tenure | 6 years |
| Phone | 770 426-0031 |
| Web | www.Artivion.com |
CryoLife Management Efficiency
The company has Return on Asset of 1.01 % which means that on every $100 spent on assets, it made $1.01 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.57 %, implying that it generated $0.57 on every 100 dollars invested. CryoLife's management efficiency ratios could be used to measure how well CryoLife manages its routine affairs as well as how well it operates its assets and liabilities.CryoLife has 363.37 M in debt with debt to equity (D/E) ratio of 1.17, which is OK given its current industry classification. CryoLife has a current ratio of 4.13, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for CryoLife to invest in growth at high rates of return.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Carlos Condorelli | Tenaris SA ADR | 68 | |
| Howard Turner | SunLink Health Systems | 76 | |
| Karen Brenner | SunLink Health Systems | 63 | |
| Faysal Kalmoua | Alvotech | 48 | |
| Roberto Bonatti | Tenaris SA ADR | 70 | |
| Simon Ayat | Tenaris SA ADR | 65 | |
| John Roche | Seadrill Limited | 44 | |
| Frederick Mohn | Transocean | 43 | |
| Giovanni Sardagna | Tenaris SA ADR | N/A | |
| Vincent Intrieri | Transocean | 63 | |
| Ek Tan | Transocean | 71 | |
| Roger Jenkins | Noble plc | 59 | |
| Jaime Puche | Tenaris SA ADR | 69 | |
| Roberto Monti | Tenaris SA ADR | 79 | |
| Frederico Curado | Transocean | 59 | |
| Samuel Merksamer | Transocean | 40 | |
| Scott Josey | Noble plc | 62 | |
| Julie Edwards | Noble plc | 62 | |
| Yves Speeckaert | Tenaris SA ADR | 59 | |
| Gianfelice Rocca | Tenaris SA ADR | 71 | |
| Glyn Barker | Transocean | 67 | |
Management Performance
| Return On Equity | 0.57 | |||
| Return On Asset | 1.01 |
CryoLife Leadership Team
Elected by the shareholders, the CryoLife's board of directors comprises two types of representatives: CryoLife inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CryoLife. The board's role is to monitor CryoLife's management team and ensure that shareholders' interests are well served. CryoLife's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CryoLife's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James Mackin, Chairman of the Board, President, Chief Executive Officer, Director | ||
| Anthony Semedo, Independent Director | ||
| Daniel Bevevino, Independent Director | ||
| Dennis Maier, Vice President - Operations | ||
| Ronald McCall, Presiding Independent Director | ||
| Thomas Bogenschutz, Senior Vice President - EMEA, General Manager - Hechingen | ||
| Jeffrey Burbank, Independent Director | ||
| Jon Salveson, Independent Director | ||
| Jean Holloway, Senior Vice President, Chief Compliance Officer, General Counsel, Secretary | ||
| Thomas Ackerman, Independent Director | ||
| F Barthold, Vice President - Research and Development | ||
| Harvey Morgan, Independent Director | ||
| Amy Horton, Chief Accounting Officer, Vice President | ||
| Scott Capps, Vice President - Clinical Research | ||
| Marna Borgstrom, Independent Director | ||
| Michael Simpson, Senior Vice President - Regulatory Affairs and Quality Assurance | ||
| John Davis, Senior Vice President - Global Sales and Marketing | ||
| James Bullock, Independent Director | ||
| Matthew Getz, Vice President - Human Resources | ||
| D Lee, Chief Financial Officer, Chief Operating Officer, Executive Vice President |
CryoLife Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CryoLife a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.57 | |||
| Return On Asset | 1.01 | |||
| Profit Margin | 0.63 % | |||
| Operating Margin | 12.82 % | |||
| Current Valuation | 1.07 B | |||
| Shares Outstanding | 39.33 M | |||
| Shares Owned By Insiders | 3.70 % | |||
| Shares Owned By Institutions | 83.78 % | |||
| Number Of Shares Shorted | 3.47 M | |||
| Price To Earning | 425.71 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in CryoLife Stock
If you are still planning to invest in CryoLife check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CryoLife's history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |